Past Events
Host of Annual In-Person Emerging Medtech Summit
(recognized as the must-attend event by thought-leading strategics & VCs)
Current Event
Welcome to Q1 2019 Emerging Medical Technologies Spotlight
Access from your Desktop on March 29, 2019 10am PT
AVVie
Implant for the treatment of mitral valve regurgitation
Jozef Tanczos
CSO
Olympus
We are seeking safe and efficient solutions that deliver minimally invasive treatment in the following fields:
-Flexible endoscopic procedures in the Gastrointestinal & Respiratory fields
-Laparoscopic surgery & Gynecological surgery in the General Surgery field
-Flexible or rigid endoscopic procedures in the Urology & Gynecology fields
-Flexible endoscopic procedures in the Ear, Nose and Throat field
Please contact us: medtech_innovation@Olympus.com
(Note) Any ideas, documents or information submitted in contacting us should be on a non-confidential basis. All ideas must have a patent filing.
Olympus -
Adan Medical Innovation
Our technology combines an app with a smartcase for autoinjectors to help patients manage their condition. Our first product, anAPPhylaxis, is for allergic individuals that have to carry at all times 2 epinephrine autoinjectors to prevent death in case of anaphylaxis, an extreme allergic reaction.
Xavier Guillem
Ximedica
For more than 30 years Ximedica has provided a unique growth platform enabling organizations to successfully deploy medical technology products into the market. Ximedica was formed in 1985 by two Rhode Island School of Design (RISD) graduates, Aidan Petrie and Stephen Lane. From those earliest days to today, the application of "human-centered" design thinking to the innovation and product creation processes remains central to the company's success. In 2014 SV Life Sciences purchased a majority stake in the firm, recognizing that Ximedica is unique in providing a comprehensive service platform - a much needed option in the evolving ecosystem of outsourced medical device development. Throughout its history Ximedica has unearthed new opportunities for clients, solved difficult development challenges, delivered cutting edge innovative solutions and added considerably to patent counts. www.ximedica.com
Joe Gordon
Director of Innovation
AuriGen Medical
John Thompson
Co-founder
Cleveland Diagnostics
CDx is a development stage diagnostics company with a proprietary technology and ready to market high-performance, low-cost blood-based tests for early detection and diagnosis of cancer, when it can be treated and cured.
Arnon Chait
President & CEO
Impleo Medical
Company is developing a device therapy for Gastroesophageal Reflux Disease (GERD). The device is injected in the lower esophagus in a one-time procedure during GI endoscopy with no overnight hospital stay.
Juliana Elstad
President & CEO
Medical Ingenuities
Richard - Chip Corrigan
CEO
Suono Bio
Use of low frequency ultrasound to deliver unformulated therapeutics such as mRNA, siRNA, macromolecules directly into tissue. Initial focus on gastrointestional system and skin diseases.
Lisa Ricciardi
CEO
SUTUREGARD Medical
Suture-based solutions for wound management
Daniel Ladizinsky
CEO
ThermopeutiX
The TwinFlo™ Catheter is designed to treat and protect the ischemic brain by providing rapid and selective cerebral hypothermia. It will offer a major advancement to the technology and treatment paradigms available to patients facing serious neurological damage and death. The unique design of TwinFlo™ results in more rapid and deeper localized cooling of the brain, while maintaining the remainder of the body at normal temperature (selective hypothermia). This differs from other hypothermia treatments that are unable to bring the brain to a sufficiently low temperature without significant total-body cooling and detrimental systemic effects. The design also permits selective drug and/or device delivery concurrent with the hypothermia treatment.
Ronald Solar
CEO